NeurAxis, Inc.
General ticker "NRXS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $43.2M (TTM average)
NeurAxis, Inc. follows the US Stock Market performance with the rate: 47.0%.
Estimated limits based on current volatility of 2.6%: low 6.02$, high 6.34$
Factors to consider:
- Total employees count: 21 (+10.5%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Commercialization delays, Market acceptance, Market competition, Supply chain disruptions
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.50$, 5.79$]
- 2026-12-31 to 2027-12-31 estimated range: [2.20$, 5.17$]
Financial Metrics affecting the NRXS estimates:
- Positive: with PPE of -4.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -17.39 <= 0.30
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Investing cash flow per share per price, % of -0.35 > -0.65
Short-term NRXS quotes
Long-term NRXS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.46MM | $2.69MM | $3.57MM |
| Operating Expenses | $9.12MM | $9.84MM | $11.40MM |
| Operating Income | $-6.66MM | $-7.16MM | $-7.83MM |
| Non-Operating Income | $-7.96MM | $-1.08MM | $0.03MM |
| Interest Expense | $0.48MM | $0.17MM | $0.07MM |
| R&D Expense | $0.17MM | $0.21MM | $0.49MM |
| Income(Loss) | $-14.63MM | $-8.24MM | $-7.80MM |
| Net Income(Loss)* | $-14.63MM | $-8.24MM | $-7.80MM |
| Stockholders Equity | $-1.40MM | $2.07MM | $3.40MM |
| Inventory | $0.02MM | $0.04MM | $0.26MM |
| Assets | $0.51MM | $4.76MM | $6.40MM |
| Operating Cash Flow | $-6.69MM | $-6.10MM | $-6.43MM |
| Capital expenditure | $0.07MM | $0.03MM | $0.03MM |
| Investing Cash Flow | $-0.07MM | $-0.03MM | $-0.13MM |
| Financing Cash Flow | $6.59MM | $9.74MM | $7.83MM |
| Earnings Per Share** | $-2.32 | $-1.19 | $-0.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.